3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
5
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Fatigue
4
Breast Neoplasms
2
Vomiting
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sleep Wake Disorders
1
Sarcoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Pain
1
Nausea
1
Lung Neoplasms
1
Leukemia
1
Infections
1
Endometrial Stromal Tumors
1
Endometrial Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Brain Neoplasms
1
Anxiety Disorders
1
Adenocarcinoma of Lung
1
Interventions
Fluorouracil
20
Leucovorin
18
Oxaliplatin
11
Irinotecan
10
Capecitabine
6
Bevacizumab
5
Cetuximab
4
Levamisole
3
Celecoxib
3
cediranib
2
Watchful Waiting
2
Tegafur
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Folfox protocol
2
Counseling
2
Cisplatin
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tipifarnib
1
regorafenib
1
pertuzumab
1
olaparib
1
mercaptoundecahydrododecaborate
1
gevokizumab
1
eniluracil
1
cemiplimab
1
brivanib
1
alpha-Tocopherol
1
Vitamin E
1
Uracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Colonic Neoplasms
×
Therapeutics
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts